🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Virginia › Arlington

Etid klinik pou Maladi kadyovaskilè nan Arlington, VA

13 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Arlington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Seven Corners Medical Center, Falls Church · 4 mi lwen
  • Carient Heart and Vascular, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi lwen
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Ap rekriteFaz 3
  • Clinical Trial Site, Arlington
  • Clinical Trial Site, Falls Church · 4 mi lwen
  • Clinical Trial Site, Fairfax · 11 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Product Surveillance Registry

Ap rekriteEtid obsèvasyon
  • Falls Church, Falls Church · 4 mi lwen
  • Fairfax, Fairfax · 11 mi lwen
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Ap rekrite
  • Inova Fairfax Hospital, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • Inova Fairfax Medical Campus, Falls Church · 4 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Ap rekriteFaz 3
  • Inova Fairfax Hospital, Falls Church · 4 mi lwen
  • Virginia Heart, Falls Church · 4 mi lwen
  • Carient Heart and Vascular, Manassas · 22 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Falls Church · 4 mi lwen
  • Research Site, Fairfax · 11 mi lwen
  • Research Site, Manassas · 22 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
  • Inova Cardiology - Fairfax, Fairfax · 11 mi lwen
  • Carient Heart and Vascular, Manassas · 22 mi lwen
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012

Global Paradise System US Post Approval Study

Ap rekriteEtid obsèvasyon
  • Inova Fairfax Hospital, Fairfax · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Ap rekriteFaz 3
  • Virginia Heart, Falls Church · 4 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT06813911

ELEVATE-HFpEF Clinical Study

Ap rekrite
  • Inova Fairfax Hospital, Falls Church · 4 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT06678841

Etid Maladi kadyovaskilè nan lòt vil

Lòt etid nan Arlington

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.